It is a healthcare public not for profit company based in Karnataka, Karnataka, India, established in 1989.
1989 | Karnataka, Karnataka, India | ActiveSada Sharada Tumor And Research Institute, a active public not for profit company, was established on 20 February 1989 in Karnataka, Karnataka, India. Engaging in preventive health services within the hospital and medical care sector, it holds CIN: U85110KA1989NPL009862. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹6.00 Cr and a paid-up capital of ₹5.98 Cr.
It upholds a compliant status. Employing 260 professional, Its leadership includes Basavlinga Amarkumar (Director), Anjali Rossi Ajaikumar (Director), Basavalinga Ajaikumar Sadasivaiah (Director). Past directors included Narasimhan Suryanarayanarao. It holds ₹4.25 Cr open charges and ₹4.70 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 438, Hebbal Areamysore Karnataka, Karnataka, Karnataka, 560017.
U85110KA1989NPL009862
009862
20 February 1989
₹6.00 Cr
₹5.98 Cr
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Sada Sharada Tumor And Research Institute — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Basavlinga Amarkumar | Director | 20 Feb 1989 | Current |
| Anjali Rossi Ajaikumar | Director | 19 Mar 2018 | Current |
| Basavalinga Ajaikumar Sadasivaiah | Director | 20 Feb 1989 | Current |
| Bhagya Adaveesh Ajaikumar | Director | 30 Sep 1993 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Company Secretary | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sada Sharada Tumor And Research Institute, for the financial year ended 2023, experienced significant growth in revenue, with a 26.34% increase. The company also saw a substantial fall in profitability, with a 20.14% decrease in profit. The company's net worth Soared by an impressive increase of 22.23%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Sada Sharada Tumor And Research Institute had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹42,500,000.00
₹4,700,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Mar 2023 | Yes Bank Limited | ₹4.25 Cr | Open |
| 26 Nov 2013 | Syndicate Bank | ₹4.70 M | Satisfied |
Explore comprehensive loan charge details -
Sada Sharada Tumor And Research Institute has a workforce of 260 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sada Sharada Tumor And Research Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sada Sharada Tumor And Research Institute's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Sada Sharada Tumor And Research Institute last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Sada Sharada Tumor And Research Institute has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was recorded as a recent event.
A charge with Yes Bank Limited amounted to Rs. 4.25 Cr with Charge ID 100687089 was registered on 14 Mar 2023. was recorded as a recent event.
A charge registered on 26 Nov 2013 via Charge ID 10463010 with Syndicate Bank was fully satisfied on 28 Oct 2022. was recorded as a recent event.
Progress on Anjali Rossi Ajaikumar was appointed as a Director was appointed as a Director on 19 Mar 2018 & has been associated with this company since 7 years 9 months . was documented.
Progress on A charge with Syndicate Bank amounted to Rs. 0.47 Cr with Charge ID 10463010 was registered on 26 Nov 2013. was documented.
The CIN of Sada Sharada Tumor And Research Institute is U85110KA1989NPL009862.
Sada Sharada Tumor And Research Institute is headquartered at 438, Hebbal Areamysore Karnataka, Karnataka, Karnataka, 560017.
Sada Sharada Tumor And Research Institute was incorporated on 20 February 1989.
The current directors of Sada Sharada Tumor And Research Institute are
The primary industry of Sada Sharada Tumor And Research Institute is Hospital And Medical Care.
Sada Sharada Tumor And Research Institute is unlisted.
The authorized capital of Sada Sharada Tumor And Research Institute is ₹6.00 Cr, and the paid-up capital is ₹5.98 Cr.
The compliance status of Sada Sharada Tumor And Research Institute is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX